GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
Rating: NVCR
Underweight $16

NovoCure (NVCR) rated to Underweight with price target $16 by Barclays

Tuesday,  Jan 19, 2016  1:25 PM ET by Betsy O'Brien Harrison

Barclays rated NovoCure
(NVCR) to Underweight with price target $16.



Barclays



RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy